GZMB and neoplasm: In immunocompetent mouse models, administration of the PDPN-targeting inhibitory peptide CY12-RP2 enhanced T cell infiltration and increased the cytotoxic activity of CD8+Granzyme B+ T cells, which are fundamental for perforin–granzyme B-dependent tumor cell lysis.